Personal information

Other IDs

SciProfiles: 1232598

Activities

Collapse all

Works (11)

Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma

Cancers
2023-09-28 | Journal article
DOI: 10.3390/cancers15194763
Contributors: Yasunori Minami; Tomoko Aoki; Satoru Hagiwara; Masatoshi Kudo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma

Liver Cancer
2023-05-11 | Journal article
DOI: 10.1159/000531024
Contributors: Tomoko Aoki; Masatoshi Kudo; Kazuomi Ueshima; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Hiroshi Ida; Yasunori Minami; Masakatsu Tsurusaki et al.
Source: check_circle
Crossref

Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma

Cancers
2023-04-20 | Journal article
DOI: 10.3390/cancers15082379
Contributors: Naoshi Nishida; Tomoko Aoki; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Hiroshi Ida; Satoru Hagiwara; Yasunori Minami; Kazuomi Ueshima; Masatoshi Kudo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma

Cancers
2023-04-15 | Journal article
DOI: 10.3390/cancers15082311
Contributors: Masahiro Morita; Naoshi Nishida; Tomoko Aoki; Hirokazu Chishina; Masahiro Takita; Hiroshi Ida; Satoru Hagiwara; Yasunori Minami; Kazuomi Ueshima; Masatoshi Kudo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Achievement of Complete Response and Drug-free Status by Atezolizumab Plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-stage Hepatocellular Carcinoma: A Multicenter Proof-of-Concept Study

Liver Cancer
2023-02-07 | Journal article
DOI: 10.1159/000529574
Contributors: Masatoshi Kudo; Tomoko Aoki; Kazuomi Ueshima; Kaoru Tsuchiya; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Yasunori Minami; Hiroshi Ida et al.
Source: check_circle
Crossref

Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response

Cancers
2022-10-04 | Journal article
DOI: 10.3390/cancers14194850
Contributors: Yasunori Minami; Tomoko Aoki; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Hiroshi Ida; Kazuomi Ueshima; Naoshi Nishida; Masatoshi Kudo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity

Journal of Histochemistry & Cytochemistry
2022-01 | Journal article
DOI: 10.1369/00221554211056853
Contributors: Tomoko Aoki; Naoshi Nishida; Masatoshi Kudo
Source: check_circle
Crossref

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease

Cells
2021-11-21 | Journal article
DOI: 10.3390/cells10113257
Contributors: Satoru Hagiwara; Naoshi Nishida; Kazuomi Ueshima; Yasunori Minami; Yoriaki Komeda; Tomoko Aoki; Masahiro Takita; Masahiro Morita; Hirokazu Chishina; Akihiro Yoshida et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint Blockade

Cancers
2020-10 | Journal article | Author
DOI: 10.3390/cancers12103048
Contributors: Tomoko Aoki; Masatoshi Kudo; Kazuomi Ueshima; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Hiroshi Ida; Yasunori Minami; Masakatsu Tsurusaki et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Cancers
2019-07-31 | Journal article
DOI: 10.3390/cancers11081084
Contributors: Masatoshi Kudo; Kazuomi Ueshima; Stephan Chan; Tomohiro Minami; Hirokazu Chishina; Tomoko Aoki; Masahiro Takita; Satoru Hagiwara; Yasunori Minami; Hiroshi Ida et al.
Source: check_circle
Crossref

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study

Cancers
2019-07-07 | Journal article
DOI: 10.3390/cancers11070952
Contributors: Kazuomi Ueshima; Naoshi Nishida; Satoru Hagiwara; Tomoko Aoki; Tomohiro Minami; Hirokazu Chishina; Masahiro Takita; Yasunori Minami; Hiroshi Ida; Mamoru Takenaka et al.
Source: check_circle
Crossref

Peer review (3 reviews for 1 publication/grant)

Review activity for Journal of medical ultrasonics. (3)
How many people are using ORCID?